[PDF][PDF] Prevalence and associated risk factors of HTLV/HIV co-infection among people who inject drugs (PWIDs): A review

C Koech, R Lwembe, E Odari… - J Hum Virol Retrovirol, 2018 - researchgate.net
Human T-cell lymphotropic viruses type 1 and 2 (HTLV1/2) and Human Immunodeficiency
Virus (HIV) co-infections show a worldwide distribution. The prevalence varies according to …

Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug …

NC Briggs, RJ Battjes, KP Cantor… - Journal of Infectious …, 1995 - academic.oup.com
Seroprevalence of human T lymphotropic virus (HTLV) and human immunodeficiency virus
type 1 (HIV-1) was determined among 7841 intravenous drug users (IVDUs) from drug …

[HTML][HTML] Concluding Remarks for Special Issue HTLV-HIV Co-Infections

A Vallejo, M Abad-Fernández - Viruses, 2023 - mdpi.com
During the early 1980s, the first 3 human retroviruses were identified: human T-lymphotropic
virus 1 and 2 (HTLV-1 and HTLV-2) and human immunodeficiency virus (HIV). A person …

[HTML][HTML] No significant HTLV seroprevalence in German people who inject drugs

O Hohn, S Norley, C Kücherer, A Bazarbachi, H El Hajj… - PloS one, 2017 - journals.plos.org
Background Although human T-lymphotropic virus (HTLV) is transmitted via the same routes
as human immunodeficiency virus (HIV), its worldwide seroprevalence differs drastically …

HTLV-I/II seroprevalence and HIV/HTLV coinfection among US intravenous drug users

KP Cantor, SH Weiss, JJ Goedert… - JAIDS Journal of …, 1991 - journals.lww.com
Data from a continuing multiyear seroprevalence survey of human T-lymphotropic virus
types I or II (HTLV-I/II) among intravenous drug users in seven US locations were analyzed …

[HTML][HTML] Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs

E Castro, E Roger - World journal of virology, 2016 - ncbi.nlm.nih.gov
This review analyses current data concerning co-infection with hepatitis C virus (HCV) and
human T lymphotropic virus (HTLV)-1/2 in people who inject drugs (PWID), with a particular …

Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 …

MA Beilke, VLT Dorge, M Sirois… - Clinical infectious …, 2007 - academic.oup.com
Background. Human T lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) are frequent
copathogens among individuals infected with human immunodeficiency virus type 1 (HIV-1) …

HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users

A Visconti, L Visconti, R Bellocco, N Binkin… - JAIDS Journal of …, 1993 - journals.lww.com
To determine whether coinfection with HTLV-II influences the course of HIV-1 infection, we
evaluated the progression from asymptomatic HIV infection (CDC group II) to persistent …

Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection

EE Telzak, R Hershow, LA Kalish… - JAIDS Journal of …, 1998 - journals.lww.com
Objectives: To determine the seroprevalence of, and risk factors for, HTLV-I and HTLV-II
infection among HIV-infected women and women at high risk for HIV infection. Design …

HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs)

EL Jõgeda, R Avi, M Pauskar, E Kallas, T Karki… - Retrovirology, 2015 - Springer
Background HTLV-1/2 and HIV likely share the same transmission routes and thus in
Europe HTLV occurs mainly among IDUs, interests in clinical implications of HTLV-1/2 co …